HomeCompareGENMF vs MRK

GENMF vs MRK: Dividend Comparison 2026

GENMF yields 457.46% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GENMF wins by $31085.24M in total portfolio value
10 years
GENMF
GENMF
● Live price
457.46%
Share price
$0.44
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31085.30M
Annual income
$21,737,677,798.08
Full GENMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GENMF vs MRK

📍 GENMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGENMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GENMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GENMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GENMF
Annual income on $10K today (after 15% tax)
$38,883.81/yr
After 10yr DRIP, annual income (after tax)
$18,477,026,128.37/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GENMF beats the other by $18,477,017,799.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GENMF + MRK for your $10,000?

GENMF: 50%MRK: 50%
100% MRK50/50100% GENMF
Portfolio after 10yr
$15542.68M
Annual income
$10,868,843,798.11/yr
Blended yield
69.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GENMF
No analyst data
Altman Z
-17.6
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GENMF buys
0
MRK buys
0
No recent congressional trades found for GENMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGENMFMRK
Forward yield457.46%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$31085.30M$56.8K
Annual income after 10y$21,737,677,798.08$9,798.13
Total dividends collected$30254.97M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GENMF vs MRK ($10,000, DRIP)

YearGENMF PortfolioGENMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$56,446$45,745.65$11,206$366.19+$45.2KGENMF
2$301,719$241,321.81$12,650$502.35+$289.1KGENMF
3$1,528,387$1,205,547.86$14,407$694.19+$1.51MGENMF
4$7,342,688$5,707,314.39$16,585$967.82+$7.33MGENMF
5$33,482,028$25,625,351.09$19,342$1,363.89+$33.46MGENMF
6$145,030,815$109,205,045.37$22,913$1,947.19+$145.01MGENMF
7$597,269,686$442,086,714.11$27,662$2,823.89+$597.24MGENMF
8$2,340,586,079$1,701,507,515.13$34,159$4,173.35+$2340.55MGENMF
9$8,736,094,113$6,231,667,008.67$43,337$6,308.80+$8736.05MGENMF
10$31,085,298,499$21,737,677,798.08$56,776$9,798.13+$31085.24MGENMF

GENMF vs MRK: Complete Analysis 2026

GENMFStock

Generation Mining Limited, a mineral exploration and development stage company, focuses on base and precious metal deposits in Canada. It explores for zinc, lead, silver, molybdenum, copper, gold, diamond, tungsten, platinum, and palladium deposits. The company holds 100% interest in the Marathon Palladium and Copper project covering an area of 22,000 hectares located in north-western Ontario. It has an option to acquire a 100% interest in the Davidson molybdenum project located in British Columbia; and has rights to a mineral concession in the Darnley Bay project located in the Northwest Territories. The company was incorporated in 2018 and is based in Toronto, Canada.

Full GENMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GENMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GENMF vs SCHDGENMF vs JEPIGENMF vs OGENMF vs KOGENMF vs MAINGENMF vs JNJGENMF vs ABBVGENMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.